Vassiliki Economides, the Executive Vice President and Chief Financial Officer of Gritstone bio, Inc. (NASDAQ:GRTS), recently sold 12,000 shares of the company's common stock. The transaction, which took place on December 18, 2024, was executed at a price of $0.015 per share, amounting to a total value of $180. Following this sale, Economides continues to hold 250,437 shares directly.
The stock currently trades near its 52-week low, with a price-to-book ratio of 0.12. InvestingPro analysis reveals concerning financial health indicators, including an Altman Z-Score of -9.84 and a Piotroski Score of 3. Investors should note that the company's next earnings report is due in 14 days, which could be a significant catalyst for the stock price. Gritstone bio is a biotechnology company based in Emeryville, California.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.